The medtech industry continues to plug along as major news comes in about vaccines, the incoming presidential administration and more. This week’s top stories include the latest on COVID-19, Joe Biden and some additional FDA clearances, plus a major royalties spat. Want to hear more about the week’s top medtech news on MassDevice? Tom Salemi will […]
Neurological
Welcome to MassDevice's Neurological Hub, your resource for the latest news in the neurological device space. Stay informed about the innovations and business news shaping the neurological industry.
🧠 Narrow your focus with these categories:
Neuromodulation/Neurostimulation | Bioelectronic Medicine | Pain Management | Brain-Computer Interfaces
Here are the top neurological device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ 7 brain-computer interface companies you need to know
+ Brain breakthroughs: Aprinoia Therapeutics’ harnesses AI and strategic partnerships to propel neurodegenerative disease research
+ Natalizumab and PML: The complex dance of benefit and risk for MS
Latest Neurological News
Boston Scientific gains FDA nod for SCS
Boston Scientific (NYSE:BSX) announced Fridayt that it received FDA approval for its WaveWriter Alpha spinal cord stimulator systems. Marlborough, Mass.-based Boston Scientific’s WaveWriter Alpha portfolio of SCS systems includes four MRI-conditional, Bluetooth-enabled implantable pulse generators to expand personalization based on patient needs, including rechargeable and non-rechargeable options as well as coverage for multiple areas of pain, […]
BrainsGate raises $14M
Ischemic stroke treatment developer BrainsGate announced today that it secured a $14 million investment to fund future regulatory efforts. Caesarea, Israel-based BrainsGate’s funding round included contributions from new investor BNP Joint Capital Fund, which led the round along with investment and consulting firm SPERO. Elron, Medtronic, Agate, Pitango and Cipio also participated in the round. […]
IBS treatment gains FDA De Novo clearance
The FDA has granted De Novo clearance to a prescription treatment for irritable bowel syndrome (IBS) from Mahana Therapeutics. San Francisco-based Mahana Therapeutics’ Parallel uses cognitive-behavioral theory (CBT) to influence the communication between the brain and the gut to improve IBS, according to the company’s website. The device classification section of the FDA’s website confirms […]
Quanterix appoints chief operating officer
Quanterix (NSDQ:QTRX) this week said it appointed William Geist as chief operating officer, effective Nov. 16. Geist has more than 25 years of experience and most recently served as VP and general manager for Thermo Fisher Scientific’s protein and cell analysis and qPCR business units. He also held numerous sales, marketing and business development leadership roles […]
Abbott launches RF pain treatment device
Abbott (NYSE:ABT) announced today that it launched its IonicRF generator for non-surgical treatment for nervous system pain management. The recently FDA-cleared device is designed for minimally invasive treatment through radiofrequency ablation, using heat to target specific nerves and block pain signals from reaching the brain. According to a news release. it’s the first Abbott-developed RF ablation […]
Neuros Medical raises $37M
Neuromodulation technology developer Neuros Medical filed an SEC Form D to confirm the sale of nearly $37 million in equity. Willoughby Hills, Ohio-based Neuros Medical made the first sale in the new notice offering on Oct. 27, 2020, and listed in the SEC filing that it does not intend for it to last longer than […]
Medtronic paying DOJ $9.2M to settle restaurant kickback allegations
The U.S. Justice Dept. (DOJ) announced that Medtronic (NYSE:MDT) will pay a total of about $9.2 million to settle improper payment allegations. Fridley, Minn.-based Medtronic agreed to pay $8.1 million to resolve allegations of False Claims Act violations regarding kickbacks for a South Dakota neurosurgeon, along with an additional $1.11 million related to allegations of Open […]
Imperative Care appoints new president
Imperative Care announced today that its chief operating officer, Daniel Davis, was appointed as the company’s new president. Davis is slated to oversee the growth of the company’s technology portfolio for the treatment of ischemic and hemorrhagic stroke as president, according to a news release. He will continue in his role as COO and will […]
Medtronic wins FDA clearance for nerve monitoring system, acquires Ai Biomed
Medtronic (NYSE:MDT) announced today that it received FDA 510(k) clearance for its NIM Vital, and it’s acquired Ai Biomed. NIM Vital is an intraoperative nerve monitoring system designed to allow physicians to identify, confirm and monitor nerve function in an effort to reduce the risk of nerve damage during head and neck surgery, according to a […]
Medtronic issues safety notice for InterStim SureScan MRI leads
Medtronic (NYSE:MDT) recently issued an urgent field safety notice to alert users to a potential issue with its InterStim SureScan MRI leads. Fridley, Minn.-based Medtronic said in the notice out of Germany that the Medtronic Model 3560030/3560022 percutaneous extension is intended for use with the Model 978A1/978B1 InterStim SureScan MRI leads during an advanced evaluation to […]